169 related articles for article (PubMed ID: 18360704)
1. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.
Morgan EA; Forootan SS; Adamson J; Foster CS; Fujii H; Igarashi M; Beesley C; Smith PH; Ke Y
Int J Oncol; 2008 Apr; 32(4):767-75. PubMed ID: 18360704
[TBL] [Abstract][Full Text] [Related]
2. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity.
Adamson J; Morgan EA; Beesley C; Mei Y; Foster CS; Fujii H; Rudland PS; Smith PH; Ke Y
Oncogene; 2003 May; 22(18):2739-49. PubMed ID: 12743598
[TBL] [Abstract][Full Text] [Related]
3. The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.
Forootan FS; Forootan SS; Malki MI; Chen D; Li G; Lin K; Rudland PS; Foster CS; Ke Y
Int J Oncol; 2014 Jan; 44(1):265-75. PubMed ID: 24189640
[TBL] [Abstract][Full Text] [Related]
4. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
5. Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
Forootan SS; Bao ZZ; Forootan FS; Kamalian L; Zhang Y; Bee A; Foster CS; Ke Y
Int J Oncol; 2010 Jan; 36(1):69-76. PubMed ID: 19956834
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
Tölle A; Suhail S; Jung M; Jung K; Stephan C
BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
[TBL] [Abstract][Full Text] [Related]
7. The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Al Fayi MS; Gou X; Forootan SS; Al-Jameel W; Bao Z; Rudland PR; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2016 Dec; 7(50):82783-82797. PubMed ID: 27779102
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues.
Das R; Hammamieh R; Neill R; Melhem M; Jett M
Clin Cancer Res; 2001 Jun; 7(6):1706-15. PubMed ID: 11410510
[TBL] [Abstract][Full Text] [Related]
10. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells.
Jing C; Beesley C; Foster CS; Chen H; Rudland PS; West DC; Fujii H; Smith PH; Ke Y
Cancer Res; 2001 Jun; 61(11):4357-64. PubMed ID: 11389060
[TBL] [Abstract][Full Text] [Related]
11. Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro.
Hammamieh R; Chakraborty N; Das R; Jett M
J Exp Ther Oncol; 2004 Oct; 4(3):195-202. PubMed ID: 15724839
[TBL] [Abstract][Full Text] [Related]
12. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis.
Hashimoto T; Kusakabe T; Sugino T; Fukuda T; Watanabe K; Sato Y; Nashimoto A; Honma K; Kimura H; Fujii H; Suzuki T
Pathobiology; 2004; 71(5):267-73. PubMed ID: 15459486
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
[TBL] [Abstract][Full Text] [Related]
14. [Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer].
Zhou L; Zhao YH; Wang XD; Jiang SF; Li H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):228-33. PubMed ID: 25924435
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
Ohlsson G; Moreira JM; Gromov P; Sauter G; Celis JE
Mol Cell Proteomics; 2005 Apr; 4(4):570-81. PubMed ID: 15734831
[TBL] [Abstract][Full Text] [Related]
16. Expression of Adipocyte/Macrophage Fatty Acid-Binding Protein in Tumor-Associated Macrophages Promotes Breast Cancer Progression.
Hao J; Yan F; Zhang Y; Triplett A; Zhang Y; Schultz DA; Sun Y; Zeng J; Silverstein KAT; Zheng Q; Bernlohr DA; Cleary MP; Egilmez NK; Sauter E; Liu S; Suttles J; Li B
Cancer Res; 2018 May; 78(9):2343-2355. PubMed ID: 29437708
[TBL] [Abstract][Full Text] [Related]
17. Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression.
Zhang Y; Forootan SS; Kamalian L; Bao ZZ; Malki MI; Foster CS; Ke Y
Int J Oncol; 2011 Apr; 38(4):1083-91. PubMed ID: 21290088
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a fatty acid binding protein from human prostatic tissue.
Chaudry AA; Dutta-Roy AK
Lipids; 1993 May; 28(5):383-8. PubMed ID: 8316044
[TBL] [Abstract][Full Text] [Related]
19. Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain.
Shioda N; Yamamoto Y; Watanabe M; Binas B; Owada Y; Fukunaga K
J Neurosci; 2010 Feb; 30(8):3146-55. PubMed ID: 20181611
[TBL] [Abstract][Full Text] [Related]
20. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
